口服傷寒疫苗市場：依通路和地區分類

Oral Typhoid Vaccine Market, By Distribution Channel (Hospitals and Clinics, Hospital Pharmacies, Retail Pharmacie, Online Pharmacies, and Others), By Geography (North America, Europe, Asia Pacific, Latin America, Middle East)

出版日期: 2026年04月29日 | 出版商:

Coherent Market Insights | 英文 250+ Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計到2026年，口服傷寒疫苗市場規模將達到1.801億美元，2033年將達到4.108億美元。預計從2026年到2033年，其複合年成長率將達到12.5%。

分析範圍		分析詳情
基準年	2025	市場規模（2026 年）	1.801億美元
效能數據	2020-2024	預測期	2026-2033
預測期（2026-2033 年）複合年成長率	12.50%	預計金額（2033 年）	4.108億美元

傷寒是由傷寒沙門氏菌引起的感染疾病。這種疾病仍然是全球重要的公共衛生議題，尤其是在開發中國家。每年報告的病例超過1000萬例，因此探索有效的預防措施至關重要，其中最重要的措施是口服傷寒疫苗。

口服傷寒疫苗（也稱為Ty21a）因其方便有效預防傷寒而被廣泛使用。與傳統的注射疫苗不同，這種創新疫苗採用口服給藥，使其更容易分發和接種，尤其是在醫療設施有限的地區。

市場動態：

口服傷寒疫苗市場受多種因素驅動。首先，傷寒發生率的上升使得人們對有效預防措施的需求日益成長，從而擴大了對口服傷寒疫苗的需求。此外，人們對疫苗接種益處和公共衛生措施重要性的認知不斷提高，也促進了市場成長。

然而，市場中存在一些限制因素。其中一個挑戰是許多地區醫療服務取得有限，這阻礙了口服傷寒疫苗的分發和接種。此外，疫苗生產和分銷的高成本也為醫療服務取得困難的人群接種疫苗設置了障礙。

儘管面臨這些挑戰，口服傷寒疫苗市場仍展現出巨大的成長潛力。開發經濟高效的生產流程並建立高效的分銷網路將有助於克服疫苗取得障礙。此外，持續進行的旨在提高口服傷寒疫苗有效性和安全性的研發工作也有望推動市場擴張。

本報告的主要特點

本報告揭示了各個細分市場的潛在商機，並描述了該市場中一系列有吸引力的投資提案。
此外，它還提供了有關市場促進因素和限制因素、機會、新產品發布和批准、市場趨勢、區域展望以及主要公司採取的競爭策略的重要見解。
本頁面根據公司概況、產品系列、主要趨勢、財務績效和策略等各種參數，對全球口服傷寒疫苗市場的主要公司進行了介紹。
本報告中的見解將使負責人和企業經營團隊能夠就未來的產品發布、技術更新、市場擴張和行銷策略做出明智的決策。
《全球口服傷寒疫苗市場》報告面向該行業的各種相關人員，包括投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
相關人員可以透過分析全球口服傷寒疫苗市場中使用的各種策略矩陣來促進決策。

北美洲
- 美國
- 加拿大
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 其他拉丁美洲國家
歐洲
- 英國
- 德國
- 義大利
- 法國
- 西班牙
- 俄羅斯
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- ASEAN
- 澳洲
- 韓國
- 其他亞太國家
中東
- 海灣合作理事會國家
- 以色列
- 其他中東國家
非洲
- 北非
- 中非
- 南非

第6章競爭情勢

公司簡介
- Janssen Global Services, LLC
- EMERGENT
- Berna Biotech AG
- Daewoong Pharmaceutical
- Bavarian Nordic
分析師意見

第7章

參考
分析方法
關於 Coherent Market Insights

簡介目錄

Product Code: CMI6332

Oral Typhoid Vaccine Market is estimated to be valued at USD 180.1 Mn in 2026 and is expected to reach USD 410.8 Mn by 2033, growing at a compound annual growth rate (CAGR) of 12.5% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 180.1 Mn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	12.50%	2033 Value Projection:	USD 410.8 Mn

Typhoid fever is an infectious disease which is caused by the bacterium Salmonella typhi. The disease remains a significant global health concern, particularly in developing countries. With over 10 Mn cases reported each year, it is crucial to explore effective preventive measures, the most important being the oral typhoid vaccine.

The oral typhoid vaccine which is also known as Ty21a, has gained popularity due to its convenience and effectiveness in preventing typhoid fever. Unlike traditional injectable vaccines, this innovative vaccine is administered orally, thus making it easier to distribute and administer, especially in areas with limited healthcare facilities.

Market Dynamics:

The oral typhoid vaccine market is driven by several factors. Firstly, the increasing incidence of typhoid fever has created a need for effective preventive measures, thereby boosting the demand for oral typhoid vaccines. Growing awareness about the benefits of vaccination and the importance of public health initiatives has contributed to market growth.

However, there are also certain restraints to the market. One such challenge is the limited access to healthcare services in many regions, which hinders the distribution and administration of oral typhoid vaccines. Moreover, the high cost associated with vaccine production and distribution poses a barrier to reaching underserved populations.

Despite these challenges, the oral typhoid vaccine market holds promising opportunities for growth. The development of cost-effective manufacturing processes and streamlined distribution networks can help overcome access barriers. Furthermore, ongoing research and development (R&D) efforts to enhance the efficacy and safety of oral typhoid vaccines can drive market expansion.

Key features of the study:

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global oral typhoid vaccine market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include oral typhoid vaccine market include Janssen Global Services, LLC, EMERGENT, Berna Biotech AG, Daewoong Pharmaceutical, and Bavarian Nordic
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The oral typhoid vaccine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the oral typhoid vaccine market

Detailed Segmentation:

Oral Typhoid Vaccine Market, By Distribution Channel (Revenue, USD Mn, 2021 - 2033)
Hospitals and Clinics
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Others (Government Immunization Programs etc.)
Regional Insights (Revenue, USD Mn, 2021 - 2033)
North America
- U.S.
- Canada
Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
Middle East
- GCC Countries
- Israel
- Rest of Middle East
Africa
- South Africa
- North Africa
- Central Africa
Top Companies in Oral Typhoid Vaccine Market:
Janssen Global Services, LLC
EMERGENT
Berna Biotech AG
Daewoong Pharmaceutical
Bavarian Nordic

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Distribution Channel
- Market Snippet, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Growing awareness about the benefits of vaccination
- Limited access in low-income regions
- Expanding immunization programs in developing countries
Key Highlights
Regulatory Scenario
Recent Trends
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Mergers, Acquisition, Collaborations

4. Oral Typhoid Vaccine Market, By Distribution Channel, 2021 - 2033, (US$ Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
Hospitals and Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
Others (Government Immunization Programs etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)

5. Oral Typhoid Vaccine Market, By Region, 2021 - 2033, (US$ Mn)

Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Region, 2022-2033
- Country Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Mn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Mn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Mn)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Mn)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Mn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 - 2033, (US$ Mn)
  - North Africa
  - Central Africa
  - South Africa

6. Competitive Landscape

Company Profile
- Janssen Global Services, LLC
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- EMERGENT
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Berna Biotech AG
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Daewoong Pharmaceutical
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Bavarian Nordic
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
Analyst Views